Pharmacological probes to validate biomarkers for analgesic drug development
There is an urgent need for analgesics with improved efficacy, especially in neuropathic and other chronic pain conditions. Unfortunately, in recent decades, many candidate analgesics have failed in clinical phase II or III trials despite promising preclinical results. Translational assessment tools...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
27 July 2022
|
| In: |
International journal of molecular sciences
Year: 2022, Jahrgang: 23, Heft: 15, Pages: 1-16 |
| ISSN: | 1422-0067 |
| DOI: | 10.3390/ijms23158295 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.3390/ijms23158295 Verlag, kostenfrei, Volltext: https://www.mdpi.com/1422-0067/23/15/8295 
|
| Verfasserangaben: | Johannes van Niel, Petra Bloms-Funke, Ombretta Caspani, Jose Maria Cendros, Luis Garcia-Larrea, Andrea Truini, Irene Tracey, Sonya C. Chapman, Nicolás Marco-Ariño, Iñaki F. Troconiz, Keith Phillips, Nanna Brix Finnerup, André Mouraux and Rolf-Detlef Treede |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1899580824 | ||
| 003 | DE-627 | ||
| 005 | 20241205165252.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240827s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/ijms23158295 |2 doi | |
| 035 | |a (DE-627)1899580824 | ||
| 035 | |a (DE-599)KXP1899580824 | ||
| 035 | |a (OCoLC)1475309327 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Van Niel, Johannes |e VerfasserIn |0 (DE-588)1340260387 |0 (DE-627)1899581499 |4 aut | |
| 245 | 1 | 0 | |a Pharmacological probes to validate biomarkers for analgesic drug development |c Johannes van Niel, Petra Bloms-Funke, Ombretta Caspani, Jose Maria Cendros, Luis Garcia-Larrea, Andrea Truini, Irene Tracey, Sonya C. Chapman, Nicolás Marco-Ariño, Iñaki F. Troconiz, Keith Phillips, Nanna Brix Finnerup, André Mouraux and Rolf-Detlef Treede |
| 264 | 1 | |c 27 July 2022 | |
| 300 | |a 16 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 27.08.2024 | ||
| 520 | |a There is an urgent need for analgesics with improved efficacy, especially in neuropathic and other chronic pain conditions. Unfortunately, in recent decades, many candidate analgesics have failed in clinical phase II or III trials despite promising preclinical results. Translational assessment tools to verify engagement of pharmacological targets and actions on compartments of the nociceptive system are missing in both rodents and humans. Through the Innovative Medicines Initiative of the European Union and EFPIA, a consortium of researchers from academia and the pharmaceutical industry was established to identify and validate a set of functional biomarkers to assess drug-induced effects on nociceptive processing at peripheral, spinal and supraspinal levels using electrophysiological and functional neuroimaging techniques. Here, we report the results of a systematic literature search for pharmacological probes that allow for validation of these biomarkers. Of 26 candidate substances, only 7 met the inclusion criteria: evidence for nociceptive system modulation, tolerability, availability in oral form for human use and absence of active metabolites. Based on pharmacokinetic characteristics, three were selected for a set of crossover studies in rodents and healthy humans. All currently available probes act on more than one compartment of the nociceptive system. Once validated, biomarkers of nociceptive signal processing, combined with a pharmacometric modelling, will enable a more rational approach to selecting dose ranges and verifying target engagement. Combined with advances in classification of chronic pain conditions, these biomarkers are expected to accelerate analgesic drug development. | ||
| 546 | |a Titel des übergeordneten Special issue: Pharmacology in pain management | ||
| 650 | 4 | |a analgesic | |
| 650 | 4 | |a biomarkers | |
| 650 | 4 | |a drug development | |
| 650 | 4 | |a pain | |
| 650 | 4 | |a PK/PD | |
| 650 | 4 | |a proof of concept | |
| 650 | 4 | |a proof of mechanism | |
| 700 | 1 | |a Bloms-Funke, Petra |e VerfasserIn |4 aut | |
| 700 | 1 | |a Caspani, Ombretta |d 1971- |e VerfasserIn |0 (DE-588)1059229668 |0 (DE-627)798163011 |0 (DE-576)41523171X |4 aut | |
| 700 | 1 | |a Cendros, Jose Maria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Garcia-Larrea, Luis |e VerfasserIn |4 aut | |
| 700 | 1 | |a Truini, Andrea |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tracey, Irene |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chapman, Sonya C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Marco-Ariño, Nicolás |e VerfasserIn |4 aut | |
| 700 | 1 | |a Troconiz, Iñaki F. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Phillips, Keith |e VerfasserIn |4 aut | |
| 700 | 1 | |a Finnerup, Nanna Brix |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mouraux, André |e VerfasserIn |4 aut | |
| 700 | 1 | |a Treede, Rolf-Detlef |d 1956- |e VerfasserIn |0 (DE-588)109865960 |0 (DE-627)606699856 |0 (DE-576)309492459 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of molecular sciences |d Basel : Molecular Diversity Preservation International, 2000 |g 23(2022), 15, Artikel-ID 8295, Seite 1-16 |h Online-Ressource |w (DE-627)316340715 |w (DE-600)2019364-6 |w (DE-576)281194653 |x 1422-0067 |7 nnas |a Pharmacological probes to validate biomarkers for analgesic drug development |
| 773 | 1 | 8 | |g volume:23 |g year:2022 |g number:15 |g elocationid:8295 |g pages:1-16 |g extent:16 |a Pharmacological probes to validate biomarkers for analgesic drug development |
| 856 | 4 | 0 | |u https://doi.org/10.3390/ijms23158295 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/1422-0067/23/15/8295 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240827 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 109865960 |a Treede, Rolf-Detlef |m 109865960:Treede, Rolf-Detlef |d 60000 |d 65100 |e 60000PT109865960 |e 65100PT109865960 |k 0/60000/ |k 1/60000/65100/ |p 14 |y j | ||
| 998 | |g 1059229668 |a Caspani, Ombretta |m 1059229668:Caspani, Ombretta |d 60000 |d 65100 |e 60000PC1059229668 |e 65100PC1059229668 |k 0/60000/ |k 1/60000/65100/ |p 3 | ||
| 999 | |a KXP-PPN1899580824 |e 4570996809 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 27.08.2024"],"id":{"doi":["10.3390/ijms23158295"],"eki":["1899580824"]},"title":[{"title_sort":"Pharmacological probes to validate biomarkers for analgesic drug development","title":"Pharmacological probes to validate biomarkers for analgesic drug development"}],"recId":"1899580824","language":["eng"],"origin":[{"dateIssuedDisp":"27 July 2022","dateIssuedKey":"2022"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"recId":"316340715","pubHistory":["1.2000 -"],"titleAlt":[{"title":"IJMS"}],"disp":"Pharmacological probes to validate biomarkers for analgesic drug developmentInternational journal of molecular sciences","note":["Gesehen am 17.09.20"],"title":[{"title":"International journal of molecular sciences","title_sort":"International journal of molecular sciences"}],"id":{"issn":["1422-0067","1661-6596"],"eki":["316340715"],"zdb":["2019364-6"]},"language":["eng"],"origin":[{"publisherPlace":"Basel","dateIssuedKey":"2000","dateIssuedDisp":"2000-","publisher":"Molecular Diversity Preservation International"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"pages":"1-16","extent":"16","year":"2022","volume":"23","issue":"15","text":"23(2022), 15, Artikel-ID 8295, Seite 1-16"},"physDesc":[{"extent":"Online-Ressource"}]}],"name":{"displayForm":["Johannes van Niel, Petra Bloms-Funke, Ombretta Caspani, Jose Maria Cendros, Luis Garcia-Larrea, Andrea Truini, Irene Tracey, Sonya C. Chapman, Nicolás Marco-Ariño, Iñaki F. Troconiz, Keith Phillips, Nanna Brix Finnerup, André Mouraux and Rolf-Detlef Treede"]},"person":[{"family":"Van Niel","roleDisplay":"VerfasserIn","given":"Johannes","display":"Van Niel, Johannes","role":"aut"},{"given":"Petra","role":"aut","display":"Bloms-Funke, Petra","roleDisplay":"VerfasserIn","family":"Bloms-Funke"},{"family":"Caspani","roleDisplay":"VerfasserIn","given":"Ombretta","role":"aut","display":"Caspani, Ombretta"},{"display":"Cendros, Jose Maria","role":"aut","given":"Jose Maria","roleDisplay":"VerfasserIn","family":"Cendros"},{"display":"Garcia-Larrea, Luis","role":"aut","given":"Luis","roleDisplay":"VerfasserIn","family":"Garcia-Larrea"},{"roleDisplay":"VerfasserIn","family":"Truini","given":"Andrea","display":"Truini, Andrea","role":"aut"},{"family":"Tracey","roleDisplay":"VerfasserIn","display":"Tracey, Irene","role":"aut","given":"Irene"},{"display":"Chapman, Sonya C.","role":"aut","given":"Sonya C.","family":"Chapman","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Marco-Ariño, Nicolás","given":"Nicolás","family":"Marco-Ariño","roleDisplay":"VerfasserIn"},{"family":"Troconiz","roleDisplay":"VerfasserIn","role":"aut","display":"Troconiz, Iñaki F.","given":"Iñaki F."},{"roleDisplay":"VerfasserIn","family":"Phillips","given":"Keith","role":"aut","display":"Phillips, Keith"},{"display":"Finnerup, Nanna Brix","role":"aut","given":"Nanna Brix","roleDisplay":"VerfasserIn","family":"Finnerup"},{"given":"André","role":"aut","display":"Mouraux, André","family":"Mouraux","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Treede","role":"aut","display":"Treede, Rolf-Detlef","given":"Rolf-Detlef"}],"physDesc":[{"extent":"16 S."}]} | ||
| SRT | |a VANNIELJOHPHARMACOLO2720 | ||